Pharmaceutical Drug Delivery Market Report 2025

This Pharmaceutical Drug Delivery report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The pharmaceutical drug delivery market size has grown strongly in recent years. It will grow from $1.79 trillion in 2024 to $1.9 trillion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increase in prevalence of chronic diseases, growing demand for biologics, increase in R&D investments by pharmaceutical companies, rising demand for personalized medicine, increased focus on patient compliance.

The pharmaceutical drug delivery market size is expected to see strong growth in the next few years. It will grow to $2.49 trillion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to growing demand for self-administration of drugs, increasing adoption of home healthcare, growing demand for targeted drug delivery, increase in the number of elderly people, regulatory support for drug delivery technologies. Major trends in the forecast period include advancements in drug delivery technologies, telemedicine integration, 3d printing in drug delivery, targeted drug delivery systems, continuous manufacturing processes.

The anticipated rise in the prevalence of chronic diseases is set to drive the growth of the pharmaceutical drug delivery market in the foreseeable future. The term 'prevalence of chronic diseases' denotes the total number of existing cases of chronic diseases within a specific population at a given time. Pharmaceutical drug delivery plays a crucial role in aiding patients suffering from chronic diseases by administering pharmaceutical drugs to specific areas of the body to treat various conditions. For example, the World Health Organization reports that noncommunicable diseases are responsible for 41 million deaths annually, accounting for 71% of all global deaths, with cardiovascular diseases being the leading cause. Therefore, the increasing prevalence of chronic diseases is a key factor propelling the growth of the pharmaceutical drug delivery market.

The continued expansion of telemedicine services is expected to contribute to the growth of the pharmaceutical drug delivery market. Telemedicine involves utilizing technology, such as telecommunication equipment and digital platforms, to provide remote healthcare advice, evaluations, therapy, and follow-up to patients. Integrating pharmaceutical drug delivery systems with telemedicine enhances the efficiency of healthcare delivery, ensuring that patients receive the necessary drugs, support, and advice even when they are geographically separated from healthcare practitioners or facilities. For instance, in August 2022, the Australian Digital Health Agency reported that 118. 2 million telehealth therapy services were provided to 18 million people between March 2020 and July 2022. More than 95,000 practitioners currently utilize telehealth services. Thus, the increasing adoption of telemedicine services is a driving force behind the pharmaceutical drug delivery market.

Leading companies in the pharmaceutical drug delivery market are increasingly adopting strategic partnerships to explore new transport targets and shuttle molecules, enhancing the delivery of medicines to the brain. Strategic partnerships involve companies utilizing each other's strengths and resources to achieve mutual benefits and success. For example, in September 2023, Cordance Medical, a US-based medical equipment manufacturer, entered into a strategic partnership with EXACT Therapeutics to facilitate drug delivery to the brain. This collaboration merges Cordance Medical's NeuroAccess platform, which can non-surgically open the blood-brain barrier (BBB), with EXACT Therapeutics' Acoustic Cluster Therapy (ACT) technology. The partnership aims to improve treatments for brain diseases, including tumors and neurodegenerative disorders, by making it easier for drugs to penetrate the brain. EXACT Therapeutics is a UK-based, clinical-stage biopharmaceutical company.

Major companies operating in the pharmaceutical drug delivery market are focusing on developing innovative products, such as the dual-chamber bag delivery system, to better meet the needs of their existing consumers. Dual-chamber bags are specialized containers designed for storing and delivering medications or medicinal solutions within drug delivery systems. For instance, in June 2022, Gufic Biosciences Limited introduced a new medication delivery system, Dual Chamber Bags, in India. These bags are two-chamber IV bags made of polypropylene (DEHP-free) with peelable aluminum foil, allowing the storage of unstable medications requiring reconstitution just before delivery. The peelable seal keeps the lyophilized (or powdered) medication and its diluent separate, ensuring compliance with American and EU pharmacopeias and meeting ISO7 clean room standards under cGMP.

In May 2022, Halozyme Therapeutics, a US-based biotechnology company, acquired Antares Pharma for $960 million. This strategic acquisition aims to strengthen Halozyme's position as a leading drug delivery company by incorporating Antares' specialty products. Antares Pharma is a US-based specialty pharmaceutical drug delivery company.

Major companies operating in the pharmaceutical drug delivery market include 3M Company., AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Becton Dickinson And Company, C. H. Boehringer Sohn AG & Co. KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Consort Medical plc, Eli Lilly and Company, Emergent Biosolutions Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Kite Pharma Inc., Merck & Co Inc., Nemera France SAS, Novartis AG, Pfizer Inc, Sanofi S. A., SHL Medical AG, Teva Pharmaceuticals Industries Ltd., West Pharmaceutical Services Inc., Aerogen Pharma Limited, AptarGroup Inc., Biocon Ltd., Catalent Inc., Evonik Industries AG, Inovio Pharmaceuticals Inc., Mylan NV, Sensile Medical Inc., Ypsomed Holding AG.

North America was the largest region in the pharmaceutical drug delivery market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

Pharmaceutical drug delivery refers to the process or method of administering a drug to an animal or human to achieve a therapeutic effect. It is a formulation or apparatus that allows a medicinal material to target its site of action while avoiding non-target cells, organs, or tissues.

The main types of pharmaceutical drug delivery routes of administration are oral, ocular, pulmonary, nasal, injectable, topical, and other routes. The oral route refers to the administration of a drug through the mouth, which is the most common route for drug administration due to its sustained and controlled delivery, ease of administration, and feasibility for solid dosage forms. The different pharmaceutical drug delivery applications include infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications. The different end-users include hospitals, home care settings, ASC/Clinics, and other end users.

The pharmaceutical drug delivery market research report is one of a series of new reports that provides pharmaceutical drug delivery market statistics, including pharmaceutical drug delivery industry global market size, regional shares, competitors with a pharmaceutical drug delivery market share, detailed pharmaceutical drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug delivery industry. This pharmaceutical drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical drug delivery market includes revenues earned by entities by administering a pharmaceutical compound to achieve a therapeutic effect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.